Atala Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$644K Buy
537
+4
+0.8% +$4.09K 0.39% 63
2026
Q1
$498K Buy
533
+9
+2% +$9.12K 0.33% 69
2025
Q4
$563K Hold
524
0.36% 61
2025
Q3
$400K Sell
524
-221
-30% -$164K 0.25% 76
2025
Q2
$581K Hold
745
0.4% 59
2025
Q1
$615K Hold
745
0.45% 56
2024
Q4
$575K Buy
+745
New +$617K 0.4% 58

Other funds holding LLY

Atala Financial's LLY Position: Q2 2026 in Review

Atala Financial increased its Eli Lilly (LLY) stake by 0.75% in Q2 2026, buying an estimated $4.09K and bringing the position to 537 shares worth $644K. The position accounts for 0.39% of the portfolio, ranked #63.

Atala Financial first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Atala Financial held 537 shares of Eli Lilly worth $644K as of Q2 2026.
  • Atala Financial bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.39% of Atala Financial's portfolio in Q2 2026, its #63 holding.
  • Atala Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Atala Financial's 13F filing for Q2 2026, filed 23 Jul 2026.